Dermatology experts examine hidradenitis suppurativa through three patient cases, addressing how clinicians define disease severity, recognize the hidden burden HS places on patients across the lifespan, and close the gaps that delay diagnosis. The panel reviews staging tools, biologic selection, comorbidity screening, and emerging therapies reshaping HS care.
Dermatologist moderator Dr. Raj Chovatiya and panelists Dr. Adam Friedman, Dr. Jason Hawkes, Dr. David Cotter, and Dr. Michelle Tarbox explore the evolving diagnosis and management of chronic spontaneous urticaria (CSU) through three real-world patient cases, emphasizing dermatology's expanding role and the growing arsenal of targeted therapies.
This comprehensive dermatology panel discussion establishes that achieving complete or near-complete skin clearance is the modern, attainable goal in psoriasis treatment. Experts emphasized a collaborative "treat-to-target" strategy and tailoring management through shared decision-making to move beyond adequate control toward sustained remission.
In this Dermatology Times Clinical Case Collective series, expert panelists discuss key updates and clinical insights related to atopic dermatitis. The discussion focuses on updated treatment guidelines for pediatric patients, breaking the "steroid cycle," and long-term management with PDE4 inhibitors.
Aaron Farberg, MD; Tina Bhutani, MD, MAS; Christopher Bunick, MD, PhD; and Harrison Nguyen, MD, MBA, MPH, explore the complex challenges of identifying, treating, and managing generalized pustular psoriasis—a rare, potentially life-threatening condition characterized by widespread sterile pustules—discussing its profound quality-of-life impact, common triggers, evolution of treatments from traditional systemics to targeted biologics, clinical cases highlighting emergency management and maintenance approaches, and promising future directions in diagnostics and personalized therapies.
Lisa Swanson, MD; Linda Stein Gold, MD; James Song, MD, and James Del Rosso, DO, examine comprehensive approaches to managing moderate to severe atopic dermatitis, with particular focus on JAK inhibitor therapy selection, safety monitoring, and clinical decision-making through detailed analysis of patient cases, therapeutic advances, and emerging research.
Alexa Hetzel, MS, PA-C; Andrew Mastro, MS, PA-C; TJ Chao, MPAS, PA-C, and Terry Faleye, MPAS, PA-C, explore plaque psoriasis through patient case analyses and treatment paradigm evaluations, identifying potential areas for advancement in care.
